MetLife Investment Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

MetLife Investment Management’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,457	Closed	-$141K	–	2846
2022 Q4	$141K	Hold	11,457	–	–	﹤0.01%	2444
2022 Q3	$376K	Buy	11,457 +3,367	+42%	+$95.2K	﹤0.01%	1841
2022 Q2	$152K	Hold	8,090	–	–	﹤0.01%	2483
2022 Q1	$142K	Buy	+8,090	New	+$166K	﹤0.01%	2535

MetLife Investment Management's CINC Position: Q1 2023 in Review

MetLife Investment Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 11,457 shares — an estimated $141K sold.

MetLife Investment Management first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $376K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

MetLife Investment Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
MetLife Investment Management sold 11,457 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $141K.
MetLife Investment Management first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
MetLife Investment Management's CinCor Pharma, Inc. Common Stock position peaked at $376K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.